We are live on ! Find out more
VIA

Virtus Investment Advisers Portfolio holdings

AUM $363M
1-Year Est. Return 34.89%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+34.89%
3 Year Est. Return
+131.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$363M
AUM Growth
-$5.41M
Cap. Flow
+$2.38M
Cap. Flow %
0.66%
Top 10 Hldgs %
7.17%
Holding
495
New
34
Increased
285
Reduced
131
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$2.11M
2
HSY icon
Hershey
HSY
+$2.09M
3
GILD icon
Gilead Sciences
GILD
+$2.07M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.05M
5
EIX icon
Edison International
EIX
+$2.04M

Top Sells

Rank Stock Value
1
HBAN icon
Huntington Bancshares
HBAN
+$2.13M
2
TKO icon
TKO Group
TKO
+$2.13M
3
WAT icon
Waters Corp
WAT
+$2.09M
4
STT icon
State Street
STT
+$2.07M
5
AON icon
Aon
AON
+$2.04M

Sector Composition

Rank Sector Weight
1 Healthcare 31.87%
2 Financials 20.97%
3 Technology 10.66%
4 Industrials 10.62%
5 Consumer Discretionary 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IDYA icon
301
IDEAYA Biosciences
IDYA
$3.41B
$267K 0.07%
8,014
+195
+2% +$6.54K
NUVL
302
DELISTED
Nuvalent
NUVL
$267K 0.07%
2,602
+64
+3% +$6.52K
MGTX icon
303
MeiraGTx Holdings
MGTX
$1.09B
$265K 0.07%
30,570
+746
+3% +$5.67K
ABCL icon
304
AbCellera Biologics
ABCL
$1.62B
$263K 0.07%
75,327
+1,839
+3% +$6.62K
NGNE icon
305
Neurogene
NGNE
$696M
$263K 0.07%
13,033
+317
+2% +$6.14K
ABUS icon
306
Arbutus Biopharma
ABUS
$865M
$261K 0.07%
57,895
+1,412
+2% +$6.17K
SEPN
307
Septerna Inc
SEPN
$1.49B
$258K 0.07%
10,719
+262
+3% +$6.89K
AVBP icon
308
ArriVent BioPharma
AVBP
$1.48B
$258K 0.07%
11,165
+271
+2% +$6.12K
DYN icon
309
Dyne Therapeutics
DYN
$4.04B
$257K 0.07%
14,150
+344
+2% +$5.93K
IMVT icon
310
Immunovant
IMVT
$8.09B
$256K 0.07%
10,320
+251
+2% +$6.5K
PRTA icon
311
Prothena Corp
PRTA
$458M
$256K 0.07%
26,320
+641
+2% +$5.87K
JBIO
312
Jade Biosciences
JBIO
$1.22B
$256K 0.07%
18,203
+444
+3% +$6.43K
SION
313
Sionna Therapeutics
SION
$2.06B
$256K 0.07%
6,374
+154
+2% +$5.88K
KYMR icon
314
Kymera Therapeutics
KYMR
$9.1B
$253K 0.07%
3,040
+74
+2% +$5.86K
COGT icon
315
Cogent Biosciences
COGT
$6.79B
$249K 0.07%
6,476
+159
+3% +$5.87K
JANX icon
316
Janux Therapeutics
JANX
$935M
$248K 0.07%
17,821
+433
+2% +$5.94K
BCIC
317
BCP Investment Corp
BCIC
$86.9M
$247K 0.07%
32,830
-475
-1% -$5.14K
VKTX icon
318
Viking Therapeutics
VKTX
$4.04B
$239K 0.07%
7,354
+180
+3% +$5.79K
BEAM icon
319
Beam Therapeutics
BEAM
$2.58B
$237K 0.07%
9,966
+242
+2% +$6.71K
NAMS icon
320
NewAmsterdam Pharma
NAMS
$3.47B
$234K 0.06%
7,319
+177
+2% +$5.76K
FDMT icon
321
4D Molecular Therapeutics
FDMT
$526M
$234K 0.06%
25,154
+613
+2% +$5.33K
PRME icon
322
Prime Medicine
PRME
$533M
$231K 0.06%
66,508
+1,622
+2% +$6.17K
INBX icon
323
Inhibrx
INBX
$1.2B
$230K 0.06%
3,425
+82
+2% +$6.08K
ARVN icon
324
Arvinas
ARVN
$518M
$230K 0.06%
21,676
+528
+2% +$6.54K
QURE icon
325
uniQure
QURE
$2.68B
$229K 0.06%
13,977
+341
+3% +$6.9K
11 12
13
14 15

Similar funds

RC
Reik & Co New York $363M AUM 3.03% 1-Year Est. Return
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
HS
HighVista Strategies Boston, Massachusetts $362M AUM 230.96% 1-Year Est. Return
SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
BHBT
Burke & Herbert Bank & Trust Alexandria, Virginia $362M AUM 20.5% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
MA
Modus Advisors Excelsior, Minnesota $363M AUM 22.99% 1-Year Est. Return

Virtus Investment Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, Virtus Investment Advisers held 495 positions worth $363M, down 1.5% from $368M the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.

Virtus Investment Advisers's Q1 2026 filing shows 34 new, 285 increased, 131 reduced and 45 closed positions. Its largest new stake was Hershey: 9,903 shares worth $2.06M. The largest sale was Huntington Bancshares, an estimated $2.13M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Financials and Technology.

  • Virtus Investment Advisers's largest Q1 2026 buy was Hershey: 9,903 shares worth $2.06M.
  • Virtus Investment Advisers added most to Amgen in Q1 2026, an estimated $2.11M increase.
  • Virtus Investment Advisers's biggest Q1 2026 reduction was Micron Technology, cutting an estimated $1.56M.
  • Virtus Investment Advisers fully exited Huntington Bancshares in Q1 2026, selling an estimated $2.13M.
  • Virtus Investment Advisers's ten largest holdings make up 7.2% of its $363M portfolio in Q1 2026.
  • Virtus Investment Advisers opened 34 new positions and closed 45 in Q1 2026.
  • Virtus Investment Advisers's portfolio value fell 1.5% quarter-over-quarter to $363M.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.